![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
, today announced it has wrapped up its presence at the 2025 Consumer Electronics Show (CES) and achieved key strategic milestones. The culmination of the event demonstrates that the company is poised to deliver exceptional value to its customers.
Taiwan Semiconductor
TSM
Advanced Micro Devices
AMD
Alphabet-A
GOOGL
Alphabet-C
GOOG
NVIDIA
NVDA
US Stock MarketDetailed Quotes
BBIO BridgeBio Pharma
- 33.540
- +0.530+1.61%
Close Mar 4 16:00 ET
- 33.540
- 0.0000.00%
Post 20:01 ET
6.38BMarket Cap-11.65P/E (TTM)
33.920High31.690Low2.99MVolume32.720Open33.010Pre Close98.53MTurnover2.25%Turnover RatioLossP/E (Static)190.19MShares39.47052wk High-4.35P/B4.46BFloat Cap21.62052wk Low--Dividend TTM133.09MShs Float73.500Historical High--Div YieldTTM6.76%Amplitude4.980Historical Low32.965Avg Price1Lot Size
BridgeBio Pharma Stock Forum
Sign in to post a comment
$Helix Acquisition Corp. II (HLXB.US)$ $BridgeBio Pharma (BBIO.US)$
$450M Deal Powers New Cancer-Fighting Biotech: What's Inside BridgeBio's Oncology SPAC Merger?
$450M Deal Powers New Cancer-Fighting Biotech: What's Inside BridgeBio's Oncology SPAC Merger?
1
$BridgeBio Pharma (BBIO.US)$
BBIO Secures Major EU Win: Revolutionary Heart Drug Shows 42% Mortality Reduction
BBIO Secures Major EU Win: Revolutionary Heart Drug Shows 42% Mortality Reduction
NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you d...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you d...
55
19
11
$BridgeBio Pharma (BBIO.US)$
BridgeBio Announces Commercial Progress, Program Updates, and 2025 Milestones
BridgeBio Pharma (NASDAQ: BBIO)reported significant commercial progress for its recently FDA-approved drug Attruby, with 430 prescriptions written by 248 unique physicians for ATTR-CM treatment. The company announced the completion of enrollment in three major Phase 3 clinical trials: FORTIFY (112 patients for LGMD2I/R9), CALIBRATE (70 patients for ADH1), and PROPEL 3 (114 participants f...
BridgeBio Announces Commercial Progress, Program Updates, and 2025 Milestones
BridgeBio Pharma (NASDAQ: BBIO)reported significant commercial progress for its recently FDA-approved drug Attruby, with 430 prescriptions written by 248 unique physicians for ATTR-CM treatment. The company announced the completion of enrollment in three major Phase 3 clinical trials: FORTIFY (112 patients for LGMD2I/R9), CALIBRATE (70 patients for ADH1), and PROPEL 3 (114 participants f...
3
1
$BridgeBio Pharma (BBIO.US)$ https://www.moomoo.com/news/flash/19740696?futusource=news_stock_stockpagenews&ns_stock_id=77584289451605&src=2&stock_news_tab=news&main_broker=WzEwMTdd&my_cid=105069706&client_hour_clock=24&channel=4&skintype=3&level=1&global_content=%7B%22promote_content%22%3A%22mm%3Aflash%3A19740696%22%2C%22invite%22%3A105069706%7D&data_ticket=53ba4dd539203616519b031b3b8738f8
$BridgeBio Pharma (BBIO.US)$ Buy Now it's flying up to 35
2
2
$BridgeBio Pharma (BBIO.US)$ ready for more boomboom candles
1
See FDA PDUFA update 👇
$Applied Therapeutics (APLT.US)$ : 🤔
⇨ Govorestat
‣ Classic Galactosemia
‣ PDUFA: 11/28/24 (NDA)
🗓️ Last Week’s Adcom & PDUFA decisions:
$BridgeBio Pharma (BBIO.US)$ : Approved 11/22 ✅
⇨Attruby (Acoramidis)
‣ ATTR-CM (transthyretin amyloid cardiomyopathy)
‣ PDUFA: 11/29/24 (NDA)
$AstraZeneca (AZN.US)$ : Discussion, no vote
⇨ Andexxa (coagulation factor Xa)
‣ Life-threatening or uncontrolled bleeding
‣ Adcom: 11/21/24 (sBLA)
$Jazz Pharmaceuticals (JAZZ.US)$ & $Zymeworks (ZYME.US)$ : Approve...
$Applied Therapeutics (APLT.US)$ : 🤔
⇨ Govorestat
‣ Classic Galactosemia
‣ PDUFA: 11/28/24 (NDA)
🗓️ Last Week’s Adcom & PDUFA decisions:
$BridgeBio Pharma (BBIO.US)$ : Approved 11/22 ✅
⇨Attruby (Acoramidis)
‣ ATTR-CM (transthyretin amyloid cardiomyopathy)
‣ PDUFA: 11/29/24 (NDA)
$AstraZeneca (AZN.US)$ : Discussion, no vote
⇨ Andexxa (coagulation factor Xa)
‣ Life-threatening or uncontrolled bleeding
‣ Adcom: 11/21/24 (sBLA)
$Jazz Pharmaceuticals (JAZZ.US)$ & $Zymeworks (ZYME.US)$ : Approve...
7
1
$BridgeBio Pharma (BBIO.US)$ woot woot, watch FBIO and them for sympathy
No comment yet
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
SteadyBoomBeepBeep : wow you’re the only one here